CLINICAL_TRIALS
trial_result
· 2014-03-03
Clinical Trial Update: Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate [Phase 2]
Summary
Phase 2 clinical trial update studying sodium bicarbonate to prevent contrast-induced nephropathy in oncology patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Barretos Cancer Hospital | Conditions: Radiographic Contrast Agent Nephropathy | Phase 2 | Status: COMPLETED